发明名称 composto, composição farmacêutica, uso do composto, e, métodos de tratamento de distúrbios mediados por mglur5 e para inibição da ativação de receptores de mglur5
摘要 The invention relates to compounds of formula I or pharmaceutically acceptable salts or solvates thereof: where Ar<SUB>1</SUB>, Ar<SUB>2</SUB>, Hy, L, R<SUB>1</SUB>, m and n are as defined in the description. The invention also includes pharmaceutical compositions and uses thereof, processes for making the compounds, as well as methods for the medical treatment of mGluR5-mediated disorders.
申请公布号 BRPI0615163(A2) 申请公布日期 2016.09.13
申请号 BR2006PI15163 申请日期 2006.08.04
申请人 ASTRAZENECA AB 发明人 ABDELMALIK SLASSI;DONALD MCLEOD;LOUISE EDWARDS;METHVIN ISAAC;TAO XIN
分类号 A61K31/455;A61K31/4545;A61K31/497;A61K31/506;A61P1/00;A61P25/00;C07D401/12;C07D403/12;C07D413/12 主分类号 A61K31/455
代理机构 代理人
主权项
地址